slotkoers
Shenzhen S.E.
00:00:00 06-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
14,82
CNY
|
+5,48%
|
|
+6,16%
|
+2,49%
|
Fiscaal tijdperk: december |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
4.735
|
3.356
|
2.364
|
2.423
|
-
|
-
|
Bedrijfswaarde
1 |
4.735
|
3.356
|
2.364
|
2.423
|
2.423
|
2.423
|
K/w-verhouding
|
35,6
x
|
64
x
|
143
x
|
36,6
x
|
18,1
x
|
19,2
x
|
Dividendrendement
|
-
|
1,47%
|
1,87%
|
2,63%
|
4,45%
|
6,75%
|
Marktkapitalisatie/omzet
|
-
|
3,28
x
|
2,32
x
|
1,94
x
|
1,55
x
|
1,35
x
|
Bedrijfswaarde/omzet
|
-
|
3,28
x
|
2,32
x
|
1,94
x
|
1,55
x
|
1,35
x
|
Bedrijfswaarde/EBITDA
|
-
|
27,6
x
|
-
|
10,8
x
|
8,24
x
|
6,46
x
|
Bedrijfswaarde/FCF
|
-
|
-10,1
x
|
-25,9
x
|
-30,7
x
|
20,9
x
|
10,7
x
|
FCF Yield
|
-
|
-9,89%
|
-3,87%
|
-3,26%
|
4,79%
|
9,37%
|
Price to Book
|
-
|
2,39
x
|
1,74
x
|
1,57
x
|
1,49
x
|
1,43
x
|
Aantal aandelen (in duizenden)
|
166.249
|
164.531
|
163.498
|
163.498
|
-
|
-
|
Referentieprijs
2 |
28,48
|
20,40
|
14,46
|
14,82
|
14,82
|
14,82
|
Datum van publicatie
|
10/03/22
|
26/04/23
|
24/04/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
-
|
1.023
|
1.020
|
1.246
|
1.566
|
1.800
|
EBITDA
1 |
-
|
121,7
|
-
|
225
|
294
|
375
|
Bedrijfsresultaat (EBIT)
1 |
-
|
59,16
|
15,08
|
69
|
133,5
|
128
|
Operationele Marge
|
-
|
5,78%
|
1,48%
|
5,54%
|
8,53%
|
7,11%
|
Resultaat voor belastingen (EBT)
1 |
-
|
56,71
|
12,44
|
68
|
132
|
127
|
Nettowinst (verlies)
1 |
132,9
|
52,71
|
16,78
|
67,5
|
136,5
|
128
|
Nettomarge
|
-
|
5,15%
|
1,65%
|
5,42%
|
8,72%
|
7,11%
|
WPA
2 |
0,8000
|
0,3186
|
0,1011
|
0,4050
|
0,8200
|
0,7700
|
Free Cash Flow
1 |
-
|
-332,1
|
-91,39
|
-79
|
116
|
227
|
FCF-marge
|
-
|
-32,47%
|
-8,96%
|
-6,34%
|
7,41%
|
12,61%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
39,46%
|
60,53%
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
84,98%
|
177,34%
|
Dividend per aandeel
2 |
-
|
0,3000
|
0,2700
|
0,3900
|
0,6600
|
1,000
|
Datum van publicatie
|
10/03/22
|
26/04/23
|
24/04/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-332
|
-91,4
|
-79
|
116
|
227
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
3,36%
|
1,1%
|
4,33%
|
8,25%
|
7,52%
|
ROA (netto-inkomsten/totale activa)
|
-
|
1,84%
|
-
|
2,29%
|
3,69%
|
5,27%
|
Totale activa
1 |
-
|
2.865
|
-
|
2.948
|
3.699
|
2.429
|
Nettoactief per aandeel
2 |
-
|
8,520
|
8,330
|
9,430
|
9,960
|
10,30
|
Cashflow per aandeel
2 |
-
|
0,5800
|
-
|
1,610
|
1,420
|
1,760
|
Capex
1 |
-
|
429
|
184
|
179
|
109
|
100
|
Capex/omzet
|
-
|
41,92%
|
18,07%
|
14,37%
|
6,93%
|
5,55%
|
Datum van publicatie
|
10/03/22
|
26/04/23
|
24/04/24
|
-
|
-
|
-
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +2,49% | 336 mln. | | -15,92% | 75,72 mld. | | -11,01% | 6,54 mld. | | +27,50% | 3,8 mld. | | -1,25% | 3,2 mld. | | +8,61% | 1,5 mld. | | -13,83% | 1,44 mld. | | -23,86% | 1,28 mld. | | -7,62% | 1,2 mld. | | -8,44% | 1,21 mld. |
Diergeneesmiddelen
|